Martin Bexon

4PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Ugur Sahin, Alexander Muik, Isabel Vogler

|Jan 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian

|Sep 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian

Pageof 1